The Parasite-Cancer Connection review
By James Young, RN • Published 2026
The book tackles a real scientific starting point—some parasitic infections are established cancer risks—then extends into broader claims that readers should evaluate with substantially more caution.
What the book covers
The publisher describes a 22-chapter investigation covering cancer-associated parasites, tumor mimics, parasite testing, chronic inflammation, ivermectin, antiparasitic treatment claims, a parasite-cleanse protocol, and a bonus section on parasites and diabetes.
What is on solid ground?
The central fact that certain parasites are linked causally to particular cancers is well established. For example, major cancer authorities recognize Opisthorchis viverrini in relation to cholangiocarcinoma and Schistosoma haematobium in relation to bladder cancer.
Where should readers be cautious?
The publisher also makes much broader claims about parasite prevalence among cancer patients, diagnostic failure, inexpensive antiparasitic treatment versus cancer therapies, ivermectin, and a cleanse protocol. Those statements should not be treated as established cancer-treatment guidance merely because some parasites are carcinogenic.
Who may find it interesting?
Readers investigating the intersection of parasitology, infection, cancer risk and diagnostic uncertainty may find the subject matter thought-provoking. Readers should pair it with authoritative cancer and infectious-disease sources and distinguish hypotheses from established clinical guidance.
See the book for yourself
If you want to examine the author's full argument and references, you can view the book through our affiliate link.
View The Parasite-Cancer ConnectionAffiliate link — we may earn a commission.
Keep researching
Start with which parasites are actually linked to cancer, then explore parasite testing and tumor mimics.